Ascidian Therapeutics
Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.
Based based in Greater Boston Area, East Coast, New England, Northeastern US, Ascidian Therapeutics works in biotechnology, genetics, medical, therapeutics, founded in 2020.
Within the biotechnology, genetics, medical, therapeutics space, the company focuses on its core offering rather than a broad product line.
The business is associated with Greater Boston Area, East Coast, New England, Northeastern US.
It is recorded at the Series_A stage.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $90M in funding.
| Sector | Biotechnology, Genetics, Medical, Therapeutics |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2020 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $90,000,000 |
Website: www.ascidian-tx.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account